Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus

BACKGROUND: Deteriorated arterial function and high incidence of cardiovascular events characterise diabetes mellitus. Metformin and recent antidiabetic drugs, SGLT2 inhibitors, reduce cardiovascular events. We explored the possible effects of empagliflozin’s effect on top of metformin treatment on...

Descripción completa

Detalles Bibliográficos
Autores principales: Lunder, Mojca, Janić, Miodrag, Japelj, Miha, Juretič, Andrej, Janež, Andrej, Šabovič, Mišo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276165/
https://www.ncbi.nlm.nih.gov/pubmed/30509271
http://dx.doi.org/10.1186/s12933-018-0797-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276165/
https://www.ncbi.nlm.nih.gov/pubmed/30509271
http://dx.doi.org/10.1186/s12933-018-0797-6

Ejemplares similares